Abstract:Coronavirus disease 2019 (COVID-19) has become a worldwide pandemic since the end of 2019. There is an increasing number of reports on nervous system symptoms, among which encephalitis is considered a serious neurological complication of COVID-19, but there are few reports of this complication in China. Acute encephalitis has severe symptoms. If it is not identified early and treated in time, the mortality is high and the prognosis is poor. During the current global epidemic, it is necessary to pay attention to the severe nervous system symptoms of COVID-19. Therefore, this article summarizes the clinical features of COVID-19 complicated by acute encephalitis through literature review and a detailed analysis of medical records, so as to provide a reference for clinicians to deal with the cases of COVID-19 complicated by acute encephalitis.
XU Pu,WANG Lai-Shuan,ZHOU Wen-Hao. Clinical features of children with coronavirus disease 2019 complicated by acute encephalitis and related research advances[J]. CJCP, 2022, 24(12): 1301-1306.
Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19[J]. Nat Neurosci, 2021, 24(2): 168-175. PMID: 33257876. DOI: 10.1038/s41593-020-00758-5.
Cosentino G, Todisco M, Hota N, et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review[J]. Eur J Neurol, 2021, 28(11): 3856-3865. PMID: 34339563. PMCID: PMC8444743. DOI: 10.1111/ene.15045.
LaRovere KL, Riggs BJ, Poussaint TY, et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome[J]. JAMA Neurol, 2021, 78(5): 536-547. PMID: 33666649. PMCID: PMC7936352. DOI: 10.1001/jamaneurol.2021.0504.
Sandoval F, Julio K, Méndez G, et al. Neurologic features associated with SARS-CoV-2 infection in children: a case series report[J]. J Child Neurol, 2021, 36(10): 853-866. PMID: 33646895. DOI: 10.1177/0883073821989164.
Ray STJ, Abdel-Mannan O, Sa M, et al. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study[J]. Lancet Child Adolesc Health, 2021, 5(9): 631-641. PMID: 34273304. PMCID: PMC8279959. DOI: 10.1016/S2352-4642(21)00193-0.
Koupaei M, Shadab Mehr N, Mohamadi MH, et al. Clinical symptoms, diagnosis, treatment, and outcome of COVID-19-associated encephalitis: a systematic review of case reports and case series[J]. J Clin Lab Anal, 2022, 36(5): e24426. PMID: 35435264. PMCID: PMC9102669. DOI: 10.1002/jcla.24426.
McLendon LA, Rao CK, Da Hora CC, et al. Post-COVID-19 acute disseminated encephalomyelitis in a 17-month-old[J]. Pediatrics, 2021, 147(6): e2020049678. PMID: 33762311. DOI: 10.1542/peds.2020-049678.
Wong AM, Lin JJ, Toh CH, et al. Childhood encephalitis: relationship between diffusion abnormalities and clinical outcome[J]. Neuroradiology, 2015, 57(1): 55-62. PMID: 25292353. DOI: 10.1007/s00234-014-1449-5.
Wong AM, Yeh CH, Lin JJ, et al. Arterial spin-labeling perfusion imaging of childhood encephalitis: correlation with seizure and clinical outcome[J]. Neuroradiology, 2018, 60(9): 961-970. PMID: 30046856. DOI: 10.1007/s00234-018-2062-9.
Siow I, Lee KS, Zhang JJ, et al. Encephalitis as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes, and predictors[J]. European journal of neurology, 2021, 28(10): 3491-3502. PMID: 33982853. PMCID: PMC8239820. DOI: 10.1111/ene.14913.